ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,742, issued on Aug. 18, was assigned to KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (Daejeon, South Korea).

"RNA expression modulating or editing method via regulation of Cas13 protein" was invented by Won Do Heo (Daejeon, South Korea) and Jeonghye Yu (Daejeon, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a RNA expression modulating or editing method through chemical or optogenetic regulation of Cas13 protein activity. Specifically, in order to regulate the activity of Cas13 in the CRISPR-Cas13 system, a fragment of the Cas13 protein was generated to enable recombination, and a chemogenetically o...